Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Urup
Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC
Der Urologe
Urology
HLA Class II Polymorphisms and Susceptibility to Recurrent Respiratory Papillomatosis
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
HLA Class-I and Class-Ii Restricted Neoantigen Loads Predict Overall Survival in Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma
Neurology
Neurology
Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience
Neurology
Neurology
Single-Institution Retrospective Review of Patients With Recurrent Glioblastoma Treated With Bevacizumab in Clinical Practice
Health Science Reports
Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients With Recurrent Glioblastoma in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology